Global Bioanalytical Testing Market Size, Share, and Growth & Trends Analysis By Molecule (Small Molecule, Large Molecule- LC-MS Studies, Immunoassays, PK, ADA, Others, Others) By Test (ADME- In-Vivo, In-Vitro, PK, PD, Bioavailability, Bioequivalence, Others) By Workflow (Sample Preparation- Protein Precipitation, Liquid-Liquid Extraction, Solid Phase Extraction, Sample Analysis- Hyphenated technique, Chromatographic technique, Electrophoresis, Ligand Binding Assay, Mass Spectrometry, Nuclear Magnetic Resonance, Other Workflow Processes) By Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology, Other Applications) By End Use Regional Outlook, Growth Potential and Segments Forecast 2024-2031

Loading...
Bioanalytical Testing Market Size, Demand and Forecast By 2031 | Insider Market Research
  • Report ID: 237
  • No. of Pages: 120
  • Categories:
  • Published Date: August 2024

Budget constraints? Get in touch with us for special pricing

Buying Options

Original price was: $9,999.00.Current price is: $8,999.00.
Original price was: $4,999.00.Current price is: $3,999.00.
Original price was: $3,999.00.Current price is: $2,999.00.
Speak To Analyst
  • +1 (614) 602 2897
  • sales@insidermarketresearch.com
Loading...

Description

Global Bioanalytical Testing Market size was USD $4.3 Billion in 2023 and is projected to reach USD $6.1 Billion by 2031, with a CAGR of 9.7 % during the forecast period.

Global Bioanalytical Testing Market: Overview

The global bioanalytical testing market is experiencing significant growth driven by advancements in technology, increasing outsourcing of testing services, and the rising demand for personalized medicine. The industry is adopting high-throughput screening methods, automation, and advanced analytical techniques to improve testing accuracy and efficiency. Innovations in multi-omics integration and digital transformation are enabling comprehensive molecular profiling and real-time diagnostics, enhancing data management capabilities. Recent collaborations, such as that between Allumiqs and Prolytix, are leveraging AI-driven solutions and next-generation proteomics technology to accelerate drug discovery processes. This partnership aims to enhance the efficiency of bringing new therapeutics to market. There is a growing trend among pharmaceutical and biotechnology companies to outsource bioanalytical testing services to specialized firms, primarily driven by the need to reduce costs and focus on core competencies, with an increasing number of companies recognizing the benefits of partnering with contract research organizations (CROs) for their testing needs. The demand for personalized medicine is rising, with bioanalytical testing playing a crucial role in developing and validating personalized therapies, particularly in oncology, where tailored treatments are essential. The market remains highly competitive, with major players like Eurofins Scientific, Charles River Laboratories, and SGS actively expanding their service offerings through mergers, acquisitions, and partnerships. This competitive environment is expected to foster innovation and the introduction of new solutions in the bioanalytical testing space. Overall, the bioanalytical testing market is poised for robust growth, driven by technological advancements, increased outsourcing, and a focus on personalized medicine. As the industry evolves, the integration of innovative technologies and strategic partnerships will be key to meeting the complex demands of drug development and regulatory compliance.

Global Bioanalytical Testing Market: Market Dynamics

Growth Drivers

1. Technological Advancements in Bioanalytical Testing

Technological innovations, such as high-throughput screening, advanced chromatography, and mass spectrometry techniques, are significantly enhancing the capabilities of bioanalytical testing. These advancements allow for more precise, accurate, and rapid analysis of biological samples, driving demand across pharmaceuticals, biotechnology, and clinical research sectors. Enhanced automation and integration of AI in data analysis also reduce human error and increase efficiency, further propelling market growth. Continuous improvements in testing methodologies ensure better sensitivity and specificity, expanding the scope of applications and fostering innovation in drug development and diagnostic procedures.

2. Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases, such as diabetes, cancer, and cardiovascular conditions, necessitates extensive bioanalytical testing for early detection, monitoring, and management. With an aging global population and lifestyle changes contributing to these diseases, there is a growing demand for reliable diagnostic and therapeutic monitoring tools. Bioanalytical testing is crucial for the development of targeted therapies and personalized medicine, which are increasingly sought after in managing chronic conditions. This surge in chronic disease prevalence directly boosts the need for advanced bioanalytical services, driving market expansion.

3. Expansion of the Pharmaceutical and Biotechnology Sectors

The pharmaceutical and biotechnology industries are experiencing robust growth, driven by increased research and development activities, a surge in new drug approvals, and heightened investment in innovative therapies. Bioanalytical testing plays a critical role in drug discovery, development, and regulatory approval processes. The rising number of clinical trials and the need for precise pharmacokinetic and pharmacodynamic studies underpin the demand for sophisticated bioanalytical services. As these sectors expand, the reliance on bioanalytical testing for quality control, efficacy assessment, and compliance with stringent regulatory standards grows, fueling market growth.

Restraining Factors

1. High Costs Associated with Bioanalytical Testing

The bioanalytical testing market faces significant cost-related challenges. Advanced testing technologies and equipment, such as mass spectrometers and high-performance liquid chromatography systems, require substantial capital investment. Additionally, the operational costs, including maintenance, calibration, and skilled personnel, contribute to high overall expenses. These costs can be prohibitive for smaller research labs and emerging biotech firms, limiting market accessibility. Furthermore, stringent regulatory requirements and the need for continuous compliance add to the financial burden, potentially slowing down the adoption of advanced bioanalytical testing services.

Opportunity Factors

1. Emergence of Personalized Medicine

Personalized medicine, which tailors medical treatment to individual characteristics, is gaining significant traction. This approach relies heavily on bioanalytical testing for precise biomarker identification, pharmacogenomics, and therapeutic drug monitoring. The growing emphasis on personalized treatment plans creates a substantial demand for advanced bioanalytical services capable of delivering high accuracy and specificity. Companies specializing in bioanalytical testing have the opportunity to develop innovative solutions that cater to the needs of personalized medicine, potentially capturing a significant market share and driving growth in this niche segment.

2. Growing Demand in Emerging Markets

Emerging markets, particularly in Asia-Pacific and Latin America, present substantial growth opportunities for the bioanalytical testing market. These regions are witnessing increased healthcare expenditure, improved healthcare infrastructure, and a rising focus on R&D activities. Additionally, the growing prevalence of chronic diseases and the expanding pharmaceutical and biotechnology industries in these areas contribute to the heightened demand for bioanalytical testing services. Companies can leverage these opportunities by establishing strategic partnerships, expanding their presence, and offering cost-effective solutions tailored to the specific needs of emerging markets.

Challenges

1. Complexity of Bioanalytical Methods

The inherent complexity of bioanalytical methods poses significant challenges. Advanced techniques such as LC-MS/MS (liquid chromatography-tandem mass spectrometry) require specialized knowledge and expertise for accurate interpretation and troubleshooting. The complexity of sample preparation, extraction, and analysis processes increases the potential for variability and error. Ensuring consistent and reproducible results across different laboratories and studies demands rigorous standardization and validation procedures. Addressing these complexities requires ongoing training, method development, and adherence to best practices, which can be resource-intensive and time-consuming.

Global Bioanalytical Testing Market: Segmentation

By Molecule

  • Small Molecule
  • Large Molecule- LC-MS Studies
  • Immunoassays
  • PK
  • ADA
  • Others

By Test

  • ADME- In-Vivo
  • In-Vitro
  • PK
  • PD
  • Bioavailability
  • Bioequivalence
  • Others

By Workflow

  • Sample Preparation- Protein Precipitation
  • Liquid-Liquid Extraction
  • Solid Phase Extraction
  • Sample Analysis- Hyphenated technique
  • Chromatographic technique
  • Electrophoresis
  • Ligand Binding Assay
  • Mass Spectrometry
  • Nuclear Magnetic Resonance
  • Other Workflow Processes

By Application

  • Oncology
  • Neurology
  • Infectious Diseases
  • Gastroenterology
  • Cardiology
  • Other Applications

By End Use

  • Pharma & BioPharma Companies
  • CDMO
  • CRO

Global Bioanalytical Testing Market: Regional Insights

The North America bioanalytical testing market is experiencing significant growth, driven by advancements in biopharmaceuticals and increasing regulatory requirements. This market encompasses a range of services, including pharmacokinetic studies, bioequivalence studies, and large molecule bioanalysis, which are essential for drug development and approval processes. Major factors contributing to this growth include the rising prevalence of chronic diseases, expanding biopharmaceutical R&D activities, and the increasing complexity of drug formulations requiring sophisticated analytical techniques. Key players in the market are investing heavily in state-of-the-art technologies and expanding their service portfolios to meet the diverse needs of clients. Additionally, stringent regulatory frameworks by agencies such as the FDA necessitate comprehensive bioanalytical testing, further propelling market demand. Outsourcing trends are also prominent, as pharmaceutical companies seek cost-effective and specialized services. The region’s robust healthcare infrastructure, coupled with the presence of numerous leading biopharmaceutical firms, positions North America as a dominant force in the global bioanalytical testing market. Competitive strategies such as mergers, acquisitions, and collaborations are prevalent, aiming to enhance service capabilities and market reach. Overall, the North America bioanalytical testing market is poised for substantial growth, reflecting the dynamic interplay of technological innovation, regulatory pressures, and market expansion strategies.

The Asia Pacific bioanalytical testing market is experiencing significant growth driven by increasing demand for precise and accurate analytical methods in drug development and regulatory compliance. Factors contributing to this expansion include the rise in pharmaceutical and biopharmaceutical R&D activities, the growing prevalence of chronic diseases, and stringent regulatory guidelines mandating thorough testing for safety and efficacy. Technological advancements in bioanalytical techniques, such as LC-MS/MS and immunoassays, are enhancing the sensitivity and specificity of tests, further propelling market growth. Additionally, the outsourcing trend among pharmaceutical companies to specialized CROs (Contract Research Organizations) in the region is boosting the market, as these CROs offer cost-effective and high-quality testing services. Countries like China, India, and Japan are at the forefront, owing to their robust healthcare infrastructure, skilled workforce, and supportive government initiatives. The market is also benefiting from increased investments in healthcare and biotechnology sectors, along with the rising adoption of personalized medicine and biosimilars. However, challenges such as high costs of advanced analytical instruments and a shortage of trained professionals may hinder market expansion. Overall, the Asia Pacific bioanalytical testing market is poised for substantial growth, driven by innovation, regulatory demands, and expanding healthcare needs.

Global Bioanalytical Testing Market: Key Players

  • Thermo Fisher Scientific Inc (PPD, Inc.)
  • ICON Plc.
  • Charles River Laboratories International
  • Covance, Inc.
  • IQVIA
  • Syneos Health
  • SGS SA
  • Labcorp (Toxikon)
  • Intertek Group Plc.
  • Pace Analytical Services LLC

Global Bioanalytical Testing Market: Recent Developments

  • In May 2024, Leading international bioanalytical laboratory BioAgilytix and BBI Solutions OEM Limited (BBI) have inked a collaboration agreement. The collaboration will combine the renowned bioanalytical testing capabilities of BioAgilytix with BBI’s capacity to quickly and effectively develop unique antibody reagents of the highest calibre for a range of testing applications. For pharma and biopharma sponsors, this method streamlines a critical stage in bioanalytical testing. In the end, the more efficient service will assist clients get their novel cures closer to the market.
  • In July 2024, Waters Corp. declared the TA Instruments Rapid Screening-Differential Scanning Calorimeter (TA Instruments RS-DSC), intended for biopharmaceutical manufacturers, to be available worldwide. With a focus on antibody medicines and modified proteins, the TA Instruments RS-DSC is a high-throughput DSC designed to precisely analyse the heat stability of high-concentration biologic formulations.

Table of Content

a:2:{i:0;a:3:{s:5:”title”;s:16:”Table of Content”;s:2:”id”;s:16:”table-of-content”;s:7:”content”;s:12806:”CHAPTER 1: EXECUTIVE SUMMARY
1.1. SummaryCHAPTER 2: RESEARCH METHODOLOGY2.1. Research Process2.2. Primary Research2.3. Secondary Research2.4. Market Size Estimation2.5. Research Methodology2.6. Analyst Tools/Models/Techniques2.6.1. Notations2.7. Market Scope & Segmentation2.8. Currency & Pricing ConsideredCHAPTER 3: MARKET TRENDS3.1. Introduction3.2. Drivers3.2.1. Technological Advancements in Bioanalytical Testing3.2.2. Increasing Prevalence of Chronic Diseases3.2.3. Expansion of the Pharmaceutical and Biotechnology Sectors3.2.4. Driver 43.3. Restraints3.3.1. High Costs Associated with Bioanalytical Testing3.3.2. Restraint 23.3.3. Restraint 33.3.4. Restraint 43.4. Opportunities3.4.1. Emergence of Personalized Medicine3.4.2. Growing Demand in Emerging Markets3.4.3. Opportunity 33.4.4. Opportunity 43.5. Challenges3.5.1. Complexity of Bioanalytical Methods3.5.2. Challenge 23.5.3. Challenge 33.5.4. Challenge 43.6. Investment Feasibility Analysis3.7. Latest TrendsCHAPTER 4: MARKET ASSESSMENT4.1. Porters Five Forces Analysis4.1.1. Bargaining Power of Suppliers4.1.2. Bargaining Power of Buyers4.1.3. Threat of New Entrants4.1.4. Threat of Substitute4.1.5. Intensity of Competitive Rivalry4.2. Value Chain Analysis4.3. Market Share Analysis4.4. Impact of Key Regulations on the Market4.5. SWOT Analysis4.6. PESTEL Analysis4.7. Patent Analysis4.7.1. By MOLECULE4.7.2. By TEST4.7.3. By WORKFLOW4.7.4. By APPLICATION4.8. Roadmap Development4.9. Market Lineage Outlook4.9.1. Parent Market Outlook4.9.2. Ancillary Market OutlookCHAPTER 5: IMPACT OF RECESSION ON THE MARKET5.1. Introduction5.1.1. Short Term Impact5.1.2. Long Term ImpactCHAPTER 6: GLOBAL BIOANALYTICAL TESTING MARKET, BY MOLECULE6.1. Introduction6.1.1. Market Size & Forecast6.1.2. Global BIOANALYTICAL TESTING Market Share, by Molecule -2023 and 2031 (%)6.2. SMALL MOLECULE6.2.1. Key market Trends, Growth Factors, and Opportunities6.2.2. Market Size and Forecast, by Regions6.3. LARGE MOLECULE- LC-MS STUDIES6.3.1. Key market Trends, Growth Factors, and Opportunities6.3.2. Market Size and Forecast, by Regions6.4. IMMUNOASSAYS6.4.1. Key market Trends, Growth Factors, and Opportunities6.4.2. Market Size and Forecast, by Regions6.5. PK6.5.1. Key market Trends, Growth Factors, and Opportunities6.5.2. Market Size and Forecast, by Regions6.6. ADA6.6.1. Key market Trends, Growth Factors, and Opportunities6.6.2. Market Size and Forecast, by RegionsCHAPTER 7: GLOBAL BIOANALYTICAL TESTING MARKET, BY TEST7.1. Introduction7.1.1. Market Size & Forecast7.1.2. Global BIOANALYTICAL TESTING Market Share, TEST -2023 and 2031 (%)7.2. ADME- IN-VIVO7.2.1. Key market Trends, Growth Factors, and Opportunities7.2.2. Market Size and Forecast, by Regions7.3. IN-VITRO7.3.1. Key market Trends, Growth Factors, and Opportunities7.3.2. Market Size and Forecast, by Regions7.4. PK7.4.1. Key market Trends, Growth Factors, and Opportunities7.4.2. Market Size and Forecast, by Regions7.5. PD7.5.1. Key market Trends, Growth Factors, and Opportunities7.5.2. Market Size and Forecast, by Regions7.6. BIOAVAILABILITY7.6.1. Key market Trends, Growth Factors, and Opportunities7.6.2. Market Size and Forecast, by RegionsCHAPTER 8: GLOBAL BIOANALYTICAL TESTING MARKET, BY WORKFLOW8.1. Introduction8.1.1. Market Size & Forecast8.1.2. Cloud Storage Market Share, by WORKFLOW -2023 and 2031 (%)8.2. SAMPLE PREPARATION- PROTEIN PRECIPITATION8.2.1. Key market Trends, Growth Factors, and Opportunities8.2.2. Market Size and Forecast, by Regions8.3. LIQUID-LIQUID EXTRACTION8.3.1. Key market Trends, Growth Factors, and Opportunities8.3.2. Market Size and Forecast, by Regions8.4. SOLID PHASE EXTRACTION8.4.1. Key market Trends, Growth Factors, and Opportunities8.4.2. Market Size and Forecast, by Regions8.5. SAMPLE ANALYSIS- HYPHENATED TECHNIQUE8.5.1. Key market Trends, Growth Factors, and Opportunities8.5.2. Market Size and Forecast, by Regions8.6. CHROMATOGRAPHIC TECHNIQUE8.6.1. Key market Trends, Growth Factors, and Opportunities8.6.2. Market Size and Forecast, by RegionsCHAPTER 9: GLOBAL BIOANALYTICAL TESTING MARKET, BY APPLICATION9.1. Introduction9.1.1. Market Size & Forecast9.1.2. Global BIOANALYTICAL TESTING Market Share, by APPLICATION -2023 and 2031 (%)9.2. ONCOLOGY9.2.1. Key market Trends, Growth Factors, and Opportunities9.2.2. Market Size and Forecast, by Regions9.3. NEUROLOGY9.3.1. Key market Trends, Growth Factors, and Opportunities9.3.2. Market Size and Forecast, by Regions9.4. INFECTIOUS DISEASES9.4.1. Key market Trends, Growth Factors, and Opportunities9.4.2. Market Size and Forecast, by Regions9.5. GASTROENTEROLOGY9.5.1. Key market Trends, Growth Factors, and Opportunities9.5.2. Market Size and Forecast, by Regions9.6. CARDIOLOGY9.6.1. Key market Trends, Growth Factors, and Opportunities9.6.2. Market Size and Forecast, by RegionsCHAPTER 10: NORTH AMERICA MARKET ANALYSIS10.1. Introduction10.2. BIOANALYTICAL TESTING Market by Country10.3. North America BIOANALYTICAL TESTING Market by Country, USD Million 2019-203110.3.1. Market Size & Forecast, By MOLECULE10.3.2. Market Size & Forecast, by TEST10.3.3. Market Size & Forecast, by WORKFLOW10.3.4. Market Size & Forecast, by APPLICATION10.4. U.S.10.4.1. Market Size & Forecast, By MOLECULE10.4.2. Market Size & Forecast, by TEST10.4.3. Market Size & Forecast, by WORKFLOW10.4.4. Market Size & Forecast, by APPLICATION10.5. Canada10.5.1. Market Size & Forecast, By MOLECULE10.5.2. Market Size & Forecast, by TEST10.5.3. Market Size & Forecast, by WORKFLOW10.5.4. Market Size & Forecast, by APPLICATIONCHAPTER 11: EUROPE MARKET ANALYSIS11.1. Introduction11.2. BIOANALYTICAL TESTING Market by Country11.3. Europe BIOANALYTICAL TESTING Market by Country, USD Million 2019-203111.3.1. Market Size & Forecast, By MOLECULE11.3.2. Market Size & Forecast, by TEST11.3.3. Market Size & Forecast, by WORKFLOW11.3.4. Market Size & Forecast, by APPLICATION11.4. Germany11.4.1. Market Size & Forecast, By MOLECULE11.4.2. Market Size & Forecast, by TEST11.4.3. Market Size & Forecast, by WORKFLOW11.4.4. Market Size & Forecast, by APPLICATION11.5. France11.5.1. Market Size & Forecast, By MOLECULE11.5.2. Market Size & Forecast, by TEST11.5.3. Market Size & Forecast, by WORKFLOW11.5.4. Market Size & Forecast, by APPLICATION11.6. U.K.11.6.1. Market Size & Forecast, By MOLECULE11.6.2. Market Size & Forecast, by TEST11.6.3. Market Size & Forecast, by WORKFLOW11.6.4. Market Size & Forecast, by APPLICATION11.7. Italy11.7.1. Market Size & Forecast, By MOLECULE11.7.2. Market Size & Forecast, by TEST11.7.3. Market Size & Forecast, by WORKFLOW11.7.4. Market Size & Forecast, by APPLICATION11.8. Spain11.8.1. Market Size & Forecast, By MOLECULE11.8.2. Market Size & Forecast, by TEST11.8.3. Market Size & Forecast, by WORKFLOW11.8.4. Market Size & Forecast, by APPLICATION11.9. Benelux11.9.1. Market Size & Forecast, By MOLECULE11.9.2. Market Size & Forecast, by TEST11.9.3. Market Size & Forecast, by WORKFLOW11.9.4. Market Size & Forecast, by APPLICATION11.10. Rest of Europe11.10.1. Market Size & Forecast, By MOLECULE11.10.2. Market Size & Forecast, by TEST11.10.3. Market Size & Forecast, by WORKFLOW11.10.4. Market Size & Forecast, by APPLICATIONCHAPTER 12: ASIA-PACIFIC MARKET ANALYSIS12.1. Introduction12.2. BIOANALYTICAL TESTING Market by Country12.3. Asia Pacific Cloud Storage Market by Country, USD Million 2019-203112.3.1. Market Size & Forecast, By MOLECULE12.3.2. Market Size & Forecast, by TEST12.3.3. Market Size & Forecast, by WORKFLOW12.3.4. Market Size & Forecast, by APPLICATION12.4. China12.4.1. Market Size & Forecast, By MOLECULE12.4.2. Market Size & Forecast, by TEST12.4.3. Market Size & Forecast, by WORKFLOW12.4.4. Market Size & Forecast, by APPLICATION12.5. India12.5.1. Market Size & Forecast, By MOLECULE12.5.2. Market Size & Forecast, by TEST12.5.3. Market Size & Forecast, by WORKFLOW12.5.4. Market Size & Forecast, by APPLICATION12.6. Japan12.6.1. Market Size & Forecast, By MOLECULE12.6.2. Market Size & Forecast, by TEST12.6.3. Market Size & Forecast, by WORKFLOW12.6.4. Market Size & Forecast, by APPLICATION12.7. Australia12.7.1. Market Size & Forecast, By MOLECULE12.7.2. Market Size & Forecast, by TEST12.7.3. Market Size & Forecast, by WORKFLOW12.7.4. Market Size & Forecast, by APPLICATION12.8. South Korea12.8.1. Market Size & Forecast, By MOLECULE12.8.2. Market Size & Forecast, by TEST12.8.3. Market Size & Forecast, by WORKFLOW12.8.4. Market Size & Forecast, by APPLICATION12.9. Souethest Asia12.9.1. Market Size & Forecast, By MOLECULE12.9.2. Market Size & Forecast, by TEST12.9.3. Market Size & Forecast, by WORKFLOW12.9.4. Market Size & Forecast, by APPLICATION12.10. Rest of Asia Pacific12.10.1. Market Size & Forecast, By MOLECULE12.10.2. Market Size & Forecast, by TEST12.10.3. Market Size & Forecast, by WORKFLOW12.10.4. Market Size & Forecast, by APPLICATIONCHAPTER 13: LATIN AMERICA AND THE CARIBBEAN MARKET ANALYSIS13.1. Introduction13.2. BIOANALYTICAL TESTING Market by Country13.3. Latin America BIOANALYTICAL TESTING Market by Country, USD Million 2019-203113.3.1. Market Size & Forecast, By MOLECULE13.3.2. Market Size & Forecast, by TEST13.3.3. Market Size & Forecast, by WORKFLOW13.3.4. Market Size & Forecast, by APPLICATION13.4. Brazil13.4.1. Market Size & Forecast, By MOLECULE13.4.2. Market Size & Forecast, by TEST13.4.3. Market Size & Forecast, by WORKFLOW13.4.4. Market Size & Forecast, by APPLICATION13.5. Mexico13.5.1. Market Size & Forecast, By MOLECULE13.5.2. Market Size & Forecast, by TEST13.5.3. Market Size & Forecast, by WORKFLOW13.5.4. Market Size & Forecast, by APPLICATION13.6. Rest of Latin America13.6.1. Market Size & Forecast, By MOLECULE13.6.2. Market Size & Forecast, by TEST13.6.3. Market Size & Forecast, by WORKFLOW13.6.4. Market Size & Forecast, by APPLICATIONCHAPTER 14: THE MIDDLE EAST AND AFRICA MARKET ANALYSIS14.1. Introduction14.2. BIOANALYTICAL TESTING Market by Country14.3. MEA BIOANALYTICAL TESTING Market by Country, USD Million 2019-203114.3.1. Market Size & Forecast, By MOLECULE14.3.2. Market Size & Forecast, by TEST14.3.3. Market Size & Forecast, by WORKFLOW14.3.4. Market Size & Forecast, by APPLICATION14.4. South Africa14.4.1. Market Size & Forecast, By MOLECULE14.4.2. Market Size & Forecast, by TEST14.4.3. Market Size & Forecast, by WORKFLOW14.4.4. Market Size & Forecast, by APPLICATION14.5. Saudi Arabia14.5.1. Market Size & Forecast, By MOLECULE14.5.2. Market Size & Forecast, by TEST14.5.3. Market Size & Forecast, by WORKFLOW14.5.4. Market Size & Forecast, by APPLICATION14.6. UAE14.6.1. Market Size & Forecast, By MOLECULE14.6.2. Market Size & Forecast, by TEST14.6.3. Market Size & Forecast, by WORKFLOW14.6.4. Market Size & Forecast, by APPLICATION14.7. Rest of MEA14.7.1. Market Size & Forecast, By MOLECULE14.7.2. Market Size & Forecast, by TEST14.7.3. Market Size & Forecast, by WORKFLOW14.7.4. Market Size & Forecast, by APPLICATIONCHAPTER 15: COMPETITIVE LANDSCAPE15.1. Introduction15.2. Market Player Positioning, 202215.3. Company Evaluation Matrix15.4. Product Mapping of Top 10 Player15.5. Market Opportunities and Future Trends15.6. Competitive Heatmap15.7. Top Winning Growth Strategies15.7.1. Major Growth Strategies15.7.2. Expansion15.7.3. Merger and Acquisition15.7.4. Other DevelopmentsCHAPTER 16: COMPANY PROFILES16.1. THERMO FISHER SCIENTIFIC INC (PPD, INC.)16.1.1. Company Overview16.1.2. Key Executives16.1.3. Financial Overview16.1.4. Business Moleculenalysis16.1.5. Product Portfolio16.1.6. Key Strategic Developments16.2. ICON PLC.16.3. CHARLES RIVER LABORATORIES INTERNATIONAL16.4. COVANCE, INC.16.5. IQVIA16.6. SYNEOS HEALTH16.7. SGS SA16.8. LABCORP (TOXIKON)16.9. INTERTEK GROUP PLC.16.10. Pace Analytical Services LLC16.11. Others”;}i:1;a:3:{s:5:”title”;s:16:”Tables & Figures”;s:2:”id”;s:14:”tables-figures”;s:7:”content”;s:16119:”LIST OF TABLESTable 1. Global BIOANALYTICAL TESTING Market INDUSTRY SNAPSHOT, 2022-2031Table 2. Global BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 3. Global BIOANALYTICAL TESTING Market SMALL MOLECULE, BY REGION-2019-2031 (USD MILLION)Table 4. Global BIOANALYTICAL TESTING Market LARGE MOLECULE- LC-MS STUDIES, BY REGION-2019-2031 (USD MILLION)Table 5. Global BIOANALYTICAL TESTING Market IMMUNOASSAYS, BY REGION-2019-2031 (USD MILLION)Table 6. Global BIOANALYTICAL TESTING Market PK, BY REGION-2019-2031 (USD MILLION)Table 7. Global BIOANALYTICAL TESTING Market ADA, BY REGION-2019-2031 (USD MILLION)Table 8. Global BIOANALYTICAL TESTING Market SHARE, by TEST SIZE-2019-2031 (USD MILLION)Table 9. Global BIOANALYTICAL TESTING Market ADME- IN-VIVO, BY REGION-2019-2031 (USD MILLION)Table 10. Global BIOANALYTICAL TESTING Market IN-VITRO, BY REGION-2019-2031 (USD MILLION)Table 11. Global BIOANALYTICAL TESTING Market PK, BY REGION-2019-2031 (USD MILLION)Table 12. Global BIOANALYTICAL TESTING Market PD, BY REGION-2019-2031 (USD MILLION)Table 13. Global BIOANALYTICAL TESTING Market BIOAVAILABILITY, BY REGION-2019-2031 (USD MILLION)Table 14. Global BIOANALYTICAL TESTING Market SHARE, by WORKFLOW -2019-2031 (USD MILLION)Table 15. Global BIOANALYTICAL TESTING Market SAMPLE PREPARATION- PROTEIN PRECIPITATION, BY REGION-2019-2031 (USD MILLION)Table 16. Global BIOANALYTICAL TESTING Market LIQUID-LIQUID EXTRACTION, BY REGION-2019-2031 (USD MILLION)Table 17. Global BIOANALYTICAL TESTING Market SOLID PHASE EXTRACTION, BY REGION-2019-2031 (USD MILLION)Table 18. Global BIOANALYTICAL TESTING Market SAMPLE ANALYSIS- HYPHENATED TECHNIQUE, BY REGION-2019-2031 (USD MILLION)Table 19. Global BIOANALYTICAL TESTING Market CHROMATOGRAPHIC TECHNIQUE, BY REGION-2019-2031 (USD MILLION)Table 20. Global BIOANALYTICAL TESTING Market SHARE, APPLICATION -2019-2031 (USD MILLION)Table 21. Global BIOANALYTICAL TESTING Market FOR ONCOLOGY, BY REGION-2019-2031 (USD MILLION)Table 22. Global BIOANALYTICAL TESTING Market FOR NEUROLOGY BY REGION-2019-2031 (USD MILLION)Table 23. Global BIOANALYTICAL TESTING Market FOR INFECTIOUS DISEASES BY REGION-2019-2031 (USD MILLION)Table 24. Global BIOANALYTICAL TESTING Market FOR GASTROENTEROLOGY BY REGION-2019-2031 (USD MILLION)Table 25. Global BIOANALYTICAL TESTING Market FOR CARDIOLOGY BY REGION-2019-2031 (USD MILLION)Table 26. NORTH AMERICA BIOANALYTICAL TESTING Market BY COUNTRY, USD MILLION 2019-2031Table 27. NORTH AMERICA BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 28. NORTH AMERICA BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 29. NORTH AMERICA BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 30. NORTH AMERICA BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 31. U.S. BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 32. U.S. BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 33. U.S. BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 34. U.S. BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 35. CANADA BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 36. CANADA BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 37. CANADA BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 38. CANADA BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 39. EUROPE BIOANALYTICAL TESTING Market BY COUNTRY, USD MILLION 2019-2031Table 40. EUROPE BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 41. EUROPE BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 42. EUROPE BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 43. EUROPE BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 44. GERMANY BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 45. GERMANY BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 46. GERMANY BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 47. GERMANY BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 48. FRANCE BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 49. FRANCE BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 50. FRANCE BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 51. FRANCE BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 52. UK BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 53. UK BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 54. UK BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 55. UK BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 56. ITALY BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 57. ITALY BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 58. ITALY BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 59. ITALY BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 60. SPAIN BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 61. SPAIN BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 62. SPAIN BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 63. SPAIN BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 64. BENELUX BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 65. BENELUX BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 66. BENELUX BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 67. BENELUX BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 68. REST OF EUROPE BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 69. REST OF EUROPE BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 70. REST OF EUROPE BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 71. REST OF EUROPE BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 72. ASIA PACIFIC BIOANALYTICAL TESTING Market BY COUNTRY, USD MILLION 2019-2031Table 73. ASIA PACIFIC BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 74. ASIA PACIFIC BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 75. ASIA PACIFIC BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 76. ASIA PACIFIC BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 77. CHINA BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 78. CHINA BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 79. CHINA BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 80. CHINA BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 81. INDIA BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 82. INDIA BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 83. INDIA BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 84. INDIA BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 85. JAPAN BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 86. JAPAN BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 87. JAPAN BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 88. JAPAN BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 89. AUSTRALIA BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 90. AUSTRALIA BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 91. AUSTRALIA BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 92. AUSTRALIA BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 93. SOUTH KOREA BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 94. SOUTH KOREA BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 95. SOUTH KOREA BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 96. SOUTH KOREA BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 97. SOUETHEST ASIA BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 98. SOUETHEST ASIA BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 99. SOUETHEST ASIA BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 100. SOUETHEST ASIA BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 101. REST OF ASIA PACIFIC BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 102. REST OF ASIA PACIFIC BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 103. REST OF ASIA PACIFIC BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 104. REST OF ASIA PACIFIC BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 105. LATIN AMERICA BIOANALYTICAL TESTING Market BY COUNTRY, USD MILLION 2019-2031Table 106. LATIN AMERICA BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 107. LATIN AMERICA BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 108. LATIN AMERICA BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 109. LATIN AMERICA BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 110. BRAZIL BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 111. BRAZIL BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 112. BRAZIL BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 113. BRAZIL BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 114. MEXICO BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 115. MEXICO BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 116. MEXICO BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 117. MEXICO BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 118. REST OF LATIN AMERICA BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 119. REST OF LATIN AMERICA BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 120. REST OF LATIN AMERICA BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 121. REST OF LATIN AMERICA BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 122. MEA BIOANALYTICAL TESTING Market BY COUNTRY, USD MILLION 2019-2031Table 123. MEA BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 124. MEA BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 125. MEA BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 126. MEA BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 127. SOUTH AFRICA BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 128. SOUTH AFRICA BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 129. SOUTH AFRICA BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 130. SOUTH AFRICA BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 131. SAUDI ARABIA BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 132. SAUDI ARABIA BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 133. SAUDI ARABIA BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 134. SAUDI ARABIA BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 135. UAE BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 136. UAE BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 137. UAE BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 138. UAE BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 139. REST OF MEA BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2019-2031 (USD MILLION)Table 140. REST OF MEA BIOANALYTICAL TESTING Market SHARE, by TEST -2019-2031 (USD MILLION)Table 141. REST OF MEA BIOANALYTICAL TESTING Market SHARE, by WORKFLOW – 2019-2031 (USD MILLION)Table 142. REST OF MEA BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2019-2031 (USD MILLION)Table 143. KEY EXPANSIONS (2019-2022)Table 144. KEY MERGERS AND ACQUISITION (2019-2022)Table 145. OTHER KEY DEVELOPMENTS (2019-2022)LIST OF FIGURESFigure 1. REGIONAL ANALYSIS (2022 & 2031)Figure 2. RESEARCH PROCESSFigure 3. ANALYSIS FRAMEWORKFigure 4. IMPACT OF KEY REGULATION ON THE MARKETFigure 5. SWOT ANALYSISFigure 6. Global BIOANALYTICAL TESTING Market SHARE, by MOLECULE -2023 & 2031 (USD MILLION)Figure 7. Global BIOANALYTICAL TESTING Market , SMALL MOLECULE -2019-2031 (USD MILLION)Figure 8. Global BIOANALYTICAL TESTING Market , LARGE MOLECULE- LC-MS STUDIES -2019-2031 (USD MILLION)Figure 9. Global BIOANALYTICAL TESTING Market , IMMUNOASSAYS -2019-2031 (USD MILLION)Figure 10. Global BIOANALYTICAL TESTING Market , PK -2019-2031 (USD MILLION)Figure 11. Global BIOANALYTICAL TESTING Market , ADA -2019-2031 (USD MILLION)Figure 12. Global BIOANALYTICAL TESTING Market SHARE, by TEST -2023 & 2031 (USD MILLION)Figure 13. Global BIOANALYTICAL TESTING Market , ADME- IN-VIVO -2019-2031 (USD MILLION)Figure 14. Global BIOANALYTICAL TESTING Market , IN-VITRO -2019-2031 (USD MILLION)Figure 15. Global BIOANALYTICAL TESTING Market , PK -2019-2031 (USD MILLION)Figure 16. Global BIOANALYTICAL TESTING Market , PD -2019-2031 (USD MILLION)Figure 17. Global BIOANALYTICAL TESTING Market , BIOAVAILABILITY -2019-2031 (USD MILLION)Figure 18. Global BIOANALYTICAL TESTING Market SHARE, by WORKFLOW -2023 & 2031 (USD MILLION)Figure 19. Global BIOANALYTICAL TESTING Market , SAMPLE PREPARATION- PROTEIN PRECIPITATION -2019-2031 (USD MILLION)Figure 20. Global BIOANALYTICAL TESTING Market , LIQUID-LIQUID EXTRACTION -2019-2031 (USD MILLION)Figure 21. Global BIOANALYTICAL TESTING Market , SOLID PHASE EXTRACTION -2019-2031 (USD MILLION)Figure 22. Global BIOANALYTICAL TESTING Market , SAMPLE ANALYSIS- HYPHENATED TECHNIQUE -2019-2031 (USD MILLION)Figure 23. Global BIOANALYTICAL TESTING Market , CHROMATOGRAPHIC TECHNIQUE -2019-2031 (USD MILLION)Figure 24. Global BIOANALYTICAL TESTING Market SHARE, by APPLICATION -2023 & 2031 (USD MILLION)Figure 25. Global BIOANALYTICAL TESTING Market , ONCOLOGY -2019-2031 (USD MILLION)Figure 26. Global BIOANALYTICAL TESTING Market , NEUROLOGY -2019-2031 (USD MILLION)Figure 27. Global BIOANALYTICAL TESTING Market , INFECTIOUS DISEASES -2019-2031 (USD MILLION)Figure 28. Global BIOANALYTICAL TESTING Market , GASTROENTEROLOGY -2019-2031 (USD MILLION)Figure 29. Global BIOANALYTICAL TESTING Market , CARDIOLOGY -2019-2031 (USD MILLION)Figure 30. MARKET PLAYER POSITIONING, 2022Figure 31. COMPANY EVALUATION MATRIXFigure 32. PRODUCT MAPPING OF TOP 10 PLAYERSFigure 33. COMPETITIVE HEATMAP OF KEY PLAYERS”;}}

Tables & Figures

Frequently Asked Questions (FAQ):

  • What is the projected market size for the Global Bioanalytical Testing Market by 2031?

    The Global Bioanalytical Testing Market is projected to reach USD $6.1 billion by 2031, growing from USD $4.3 billion in 2023, with a CAGR of 9.7% during the forecast period.

  • What are the regional insights for the bioanalytical testing market?

    In North America, the market is driven by advancements in biopharmaceuticals, increasing regulatory requirements, and significant R&D activities. Asia Pacific, the market growth is propelled by rising R&D activities, the prevalence of chronic diseases, and the expansion of the pharmaceutical and biotechnology sectors.

  • Who are the major players in the Global Bioanalytical Testing Market?

    Major players include Thermo Fisher Scientific Inc (PPD, Inc.), ICON Plc., Charles River Laboratories International, Covance, Inc., IQVIA, Syneos Health, SGS SA, Labcorp (Toxikon), Intertek Group Plc., and Pace Analytical Services LLC.

Buying Options

Original price was: $9,999.00.Current price is: $8,999.00.
Original price was: $4,999.00.Current price is: $3,999.00.
Original price was: $3,999.00.Current price is: $2,999.00.
Speak To Analyst
  • +1 (614) 602 2897
  • sales@insidermarketresearch.com